Medical Devices Investors & VC Firms in United States

516 firms in this list, with a median first check of $500K. 35 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
CH China Growth Capital HWHLJX3 people · Leads rounds	88🔒	Beijing	CN	Pre-Seed–Series A	—	+ Add to CRM
PB PBM Capital PMJPJRSG6 people	88🔒	Charlottesville	US	Seed–Late Stage	—	+ Add to CRM
BA Ballast Point Ventures DGMRPJRF10 people	88🔒	Tampa	US	Growth–Late Stage	$5M – $15M	+ Add to CRM
NE Next Level Ventures CIDTDHMP10 people	88🔒	Des Moines	US	Seed–Late Stage	$500K – $5M	+ Add to CRM
CR Crossroads Health Ventures TGVWSGCL6 people	88🔒	—	US	Pre-Seed–Series A	—	+ Add to CRM
RO Roche Venture Fund DECN2 people	88🔒	Basel	CH	Series A	$648K – $3.2M	+ Add to CRM
RO Rockies Venture Adviser, Llc PACSDHKK6 people · Leads rounds	88🔒	Denver	US	Pre-Seed–Seed	—	+ Add to CRM
AV Averin Capital JLTHDB3 people	88🔒	New York	US	Seed–Growth	—	+ Add to CRM
BI Bioqube Ventures DDDRJENV9 people	88🔒	Brussels	BE	Seed–Late Stage	$108K – $6.5M	+ Add to CRM
DS dsm-firmenich Venturing SHAKADAM9 people	88🔒	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
NO Novellus Ventures Ls1 Gp, Llc FJDADDDD6 people	88🔒	Houston	US	Pre-Seed–Seed	—	+ Add to CRM
OU OUP (Osage University Partners) BHMSMSMC9 people	88🔒	Bala Cynwyd	US	Seed–Late Stage	$1M – $20M	+ Add to CRM
PM PM Equity Partner AGACCODS9 people	88🔒	Lausanne	CH	Series A–Series B	$2M – $50M	+ Add to CRM
TE Telegraph Hill Partners ACDAJMJM9 people	88🔒	San Francisco	US	Growth–Late Stage	$2M – $8M	+ Add to CRM
UN Unorthodox Ventures CSCALK3 people	88🔒	Austin	US	Seed–Series B	$1M – $5M	+ Add to CRM
TA Taiwania Capital CWILJSMH11 people	88🔒	Santa Clara	US	Seed–Series A	—	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	—	SG	Seed–Series B	—	+ Add to CRM
JA JAFCO Group AFHNHTKA8 people	88🔒	Tokyo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
AP Apollo Health Ventures NROMABJA11 people	88🔒	Berlin	DE	Seed–Series A	—	+ Add to CRM
AR Arkin Capital MAALNSPO11 people	88🔒	Herzliya	IL	Seed–Late Stage	—	+ Add to CRM
CA Catalio Capital Management, LP GCRJIRJH11 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
DI Digitalis Ventures GWABBJCC11 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
HE HealthCap AVAFBOCK11 people	88🔒	Stockholm	SE	Seed–Series A	—	+ Add to CRM
NO Noro-Moseley Partners ATAMBHSM8 people	88🔒	Atlanta	US	Series A–Late Stage	$5M – $20M	+ Add to CRM

China Growth Capital

BeijingPre-Seed–Series A

HWHLJX3 people

PBM Capital

CharlottesvilleSeed–Late Stage

PMJPJRSG6 people

Ballast Point Ventures

TampaGrowth–Late Stage$5M – $15M

DGMRPJRF10 people

Next Level Ventures

Des MoinesSeed–Late Stage$500K – $5M

CIDTDHMP10 people

Crossroads Health Ventures

Pre-Seed–Series A

TGVWSGCL6 people

Roche Venture Fund

BaselSeries A$648K – $3.2M

DECN2 people

Rockies Venture Adviser, Llc

DenverPre-Seed–Seed

PACSDHKK6 people

Averin Capital

New YorkSeed–Growth

JLTHDB3 people

Bioqube Ventures

BrusselsSeed–Late Stage$108K – $6.5M

DDDRJENV9 people

dsm-firmenich Venturing

MaastrichtPre-Seed–Late Stage$108K – $5.4M

SHAKADAM9 people

Novellus Ventures Ls1 Gp, Llc

HoustonPre-Seed–Seed

FJDADDDD6 people

OUP (Osage University Partners)

Bala CynwydSeed–Late Stage$1M – $20M

BHMSMSMC9 people

PM Equity Partner

LausanneSeries A–Series B$2M – $50M

AGACCODS9 people

Telegraph Hill Partners

San FranciscoGrowth–Late Stage$2M – $8M

ACDAJMJM9 people

Unorthodox Ventures

AustinSeed–Series B$1M – $5M

CSCALK3 people

Taiwania Capital

Santa ClaraSeed–Series A

CWILJSMH11 people

EDB Investments

Seed–Series B

CKCLCGJO11 people

JAFCO Group

TokyoPre-Seed–Late Stage

AFHNHTKA8 people

Apollo Health Ventures

BerlinSeed–Series A

NROMABJA11 people

Arkin Capital

HerzliyaSeed–Late Stage

MAALNSPO11 people

Catalio Capital Management, LP

New YorkSeed–Late Stage

GCRJIRJH11 people

Digitalis Ventures

New YorkSeed–Late Stage

GWABBJCC11 people

HealthCap

StockholmSeed–Series A

AVAFBOCK11 people

Noro-Moseley Partners

AtlantaSeries A–Late Stage$5M – $20M

ATAMBHSM8 people

Data sourced from public filings and firms' own websites — see our methodology.